Cullinan Therapeutics (CGEM) Change in Cash (2020 - 2023)
Historic Change in Cash for Cullinan Therapeutics (CGEM) over the last 4 years, with Q4 2023 value amounting to $33.6 million.
- Cullinan Therapeutics' Change in Cash rose 13882.67% to $33.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$57.7 million, marking a year-over-year decrease of 15988.71%. This contributed to the annual value of -$15.4 million for FY2024, which is 7326.83% up from last year.
- Cullinan Therapeutics' Change in Cash amounted to $33.6 million in Q4 2023, which was up 13882.67% from -$77.0 million recorded in Q3 2023.
- Cullinan Therapeutics' Change in Cash's 5-year high stood at $277.4 million during Q2 2022, with a 5-year trough of -$169.9 million in Q2 2021.
- Its 4-year average for Change in Cash is $2.2 million, with a median of -$13.8 million in 2020.
- The largest annual percentage gain for Cullinan Therapeutics' Change in Cash in the last 5 years was 80147.19% (2021), contrasted with its biggest fall of 306918.37% (2021).
- Quarter analysis of 4 years shows Cullinan Therapeutics' Change in Cash stood at $126.9 million in 2020, then crashed by 122.33% to -$28.3 million in 2021, then tumbled by 205.34% to -$86.5 million in 2022, then skyrocketed by 138.83% to $33.6 million in 2023.
- Its Change in Cash was $33.6 million in Q4 2023, compared to -$77.0 million in Q3 2023 and $19.7 million in Q2 2023.